Flu's up for Rockeby
Thursday, 24 July, 2008
Rockeby Biomed [ASX: RBY] has received international orders for its bird flu tests worth a combined $252,000.
Payments have already been received from several south-east Asian, European and north African countries, and orders are in the process of delivery over the next few weeks, the company said.
The timing of the new orders is serendipitous, as Rockeby recently announced it had withdrawn from a non-binding agreement it had reached with an unnamed south-east Asian country.
According to company spokespeople, the decision to withdraw was reached because Rockeby had not received the advance payments stipulated by the agreement.
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...
Global study finds 250 genes linked to OCD
Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
